Table 1 Baseline Characteristics
Baseline characteristics | Total sample |
|---|---|
(N=117) | |
Gender | Â |
Male | 96 (82.1%) |
Female | 21 (17.9%) |
Mean Age, years (SD) | 45.4 (±6.9) |
Ethnicity | Â |
White | 16 (13.7%) |
African-American | 63 (53.8%) |
Hispanic | 38 (32.5%) |
Anticipated Housing | Â |
Unstable Housing | 60 (51.3%) |
Homeless | 29 (24.8%) |
Stable Housing | 21 (17.9%) |
Opioid Use Disorder* | 43 (36.8%) |
Cocaine Use Disorder* | 54 (46.2%) |
Hazardous Drinking (AUDIT**) | 50 (42.7%) |
Viral Load (Baseline) | Â |
< 400 copies/mL | 92 (78.6%) |
< 50 copies/mL | 66 (56.4%) |
Mean Log HIV-1 RNA Level, cells/mL (SD) | 2.300 (±1.02) |
CD4+ lymphocytes count, cells/mL (SD) | 403.61 (±244.4) |
Addiction Severity Index Composite Scores | |
Psychiatric Composite Score (n=112) | Â |
Mean Severity Score (SD) | 0.254 (±0.25) |
High Severity (>.22) | 52 (46.4%) |
Drug Use Composite Score (n=113) | Â |
Mean Severity Score (SD) | 0.085 (±0.08) |
High Severity (>.16) | 15 (13.3%) |
Alcohol Use Composite Score (n=112) | Â |
Mean Severity Score (SD) | 0.055 (±0.11) |
High Severity (>.17) | 8 (7.1%) |
Prescribed Psychiatric Medications | 35 (29.9%) |
Anti-Depressants | 22 (18.8%) |
Anti-Psychotics | 2 (1.7%) |
Mood Stabilizers | 1 (0.9%) |
Multiple Medications | 16 (13.7%) |
Any Psychiatric Disorder (n=116)* | 55 (47.4%) |
Any Mood Disorder* | 37 (31.6%) |
Any Anxiety Disorder (n=116)* | 36 (31.0%) |
Any Thought Disorder* | 13 (11.1%) |